Indication

E. coli gynecological infections

*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E. Read more about E. coli gynecological infections

43 drugs 29 manufacturers

Advertisement

Drugs that treat it

Common E. coli gynecological infections therapies.

Showing 10–18 of 43 drugs

CEFTAZIDIME

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with E. coli gynecological infections preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About E. coli gynecological infections.

*Escherichia coli* gynecological infections encompass localized or ascending bacterial infections of the female reproductive tract caused by the Gram-negative bacillus *E.

coli*.

Affecting the female reproductive system, these conditions typically arise when pathogenic or gastrointestinal commensal strains colonize the vaginal introitus and ascend through the endocervix, often occurring in polymicrobial settings or secondary to disruption of the normal protective vaginal microbiome.

Clinically, these manifestations include endometritis, pelvic inflammatory disease, tubo-ovarian abscesses, aerobic vaginitis, and postoperative pelvic or vaginal cuff infections.

Defining features involve acute pelvic or lower abdominal pain, purulent discharge, localized tenderness, systemic signs of inflammation such as fever, and potential risks of severe suppurative sequelae or tissue necrosis.

Personalize your experience

Follow E. coli gynecological infections and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it